Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease brain cancer
Comorbidity C0017636|glioblastoma
Sentences 9
PubMedID- 26137092 Human glioblastoma multiforme is one of the most aggressive malignant brain tumor types, and the mean survival time of patients with a brain tumor is <2 years when traditional therapies are administered.
PubMedID- 22591335 We apply the method to the dti data of normal subjects and brain cancer patients with glioblastoma and show its superiority to some of the previously published methods in the literature.
PubMedID- 23016266 Background and aims: glioblastoma is one of the most malignant brain tumors, causing death within two years despite maximal tumor resection and concurrent radio-chemotherapy.
PubMedID- PMC3906255 Gapvac will address the high unmet medical need in glioblastoma, an aggressive form of brain cancer with poor prognosis, where the limited treatments available today have minimal effect on overall survival.
PubMedID- 24750704 glioblastoma multiforme represents one of the most common brain cancers with a rather heterogeneous cellular composition, as indicated by the term "multiforme".
PubMedID- 21351415 glioblastoma multiforme is one of the most aggressive malignant brain tumours with limited therapeutics options.
PubMedID- 24070814 glioblastoma is one of the most malignant brain tumors with a poor prognosis.
PubMedID- 25630625 High-grade gliomas (hgg; who grade 3 or 4) account for the majority of newly-diagnosed malignant brain tumors, with glioblastoma multiforme (gbm) representing the most common subtype [1].
PubMedID- 24900981 glioblastoma multiforme is one of the most serious malignant brain tumors and is characterized by resistance to chemotherapy and radiation therapy.

Page: 1